Trexquant Investment LP boosted its holdings in Cabot Co. (NYSE:CBT – Free Report) by 99.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 109,423 shares of the specialty chemicals company’s stock after purchasing an additional 54,429 shares during the quarter. Trexquant Investment LP’s holdings in Cabot were worth $9,991,000 as of its most recent SEC filing.
A number of other institutional investors also recently bought and sold shares of CBT. American Century Companies Inc. increased its holdings in shares of Cabot by 8.5% in the 4th quarter. American Century Companies Inc. now owns 1,323,347 shares of the specialty chemicals company’s stock valued at $120,835,000 after acquiring an additional 103,380 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Cabot by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 1,283,686 shares of the specialty chemicals company’s stock worth $143,504,000 after buying an additional 22,719 shares during the last quarter. Sei Investments Co. boosted its holdings in shares of Cabot by 6.0% in the 4th quarter. Sei Investments Co. now owns 942,273 shares of the specialty chemicals company’s stock valued at $86,039,000 after buying an additional 53,090 shares in the last quarter. Copeland Capital Management LLC boosted its holdings in shares of Cabot by 21.6% in the 4th quarter. Copeland Capital Management LLC now owns 761,372 shares of the specialty chemicals company’s stock valued at $69,521,000 after buying an additional 135,119 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in Cabot by 0.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 710,608 shares of the specialty chemicals company’s stock worth $64,886,000 after acquiring an additional 3,175 shares in the last quarter. 93.18% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities analysts have issued reports on CBT shares. JPMorgan Chase & Co. dropped their price objective on Cabot from $105.00 to $85.00 and set an “underweight” rating on the stock in a report on Friday, February 21st. Mizuho dropped their price target on Cabot from $122.00 to $110.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 7th. Finally, StockNews.com raised Cabot from a “hold” rating to a “buy” rating in a report on Tuesday. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, Cabot presently has a consensus rating of “Hold” and a consensus target price of $97.00.
Cabot Stock Up 0.5 %
CBT opened at $84.40 on Thursday. Cabot Co. has a 52 week low of $79.57 and a 52 week high of $117.46. The business has a 50 day moving average price of $85.23 and a two-hundred day moving average price of $97.76. The company has a quick ratio of 1.29, a current ratio of 2.00 and a debt-to-equity ratio of 0.72. The company has a market cap of $4.58 billion, a PE ratio of 11.21, a P/E/G ratio of 0.74 and a beta of 1.21.
Cabot (NYSE:CBT – Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. As a group, research analysts anticipate that Cabot Co. will post 7.57 EPS for the current year.
Cabot Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were issued a dividend of $0.43 per share. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.72 annualized dividend and a yield of 2.04%. Cabot’s dividend payout ratio is currently 22.84%.
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
See Also
- Five stocks we like better than Cabot
- What is the NASDAQ Stock Exchange?
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Dividend Payout Ratio Calculator
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Using the MarketBeat Dividend Yield Calculator
- Analyst Targets Signal More Growth in CrowdStrike Stock
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.